Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1139 Results

Title
Intervention Indication Therapeutic Area Year Actions
Dupilumab for eosinophilic oesophagitis in paediatric patients Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893) Eosinophilic oesophagitis Gastroenterology , Immunology 2023 View  |  Download
Dupilumab for children aged 6 to less than 12 years with severe atopic dermatitis Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893) Atopic dermatitis Dermatology 2019 View  |  Download
Dupilumab for Children Aged 12 Years to 17 Years with Moderate to Severe Atopic Dermatitis Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893) Atopic dermatitis Dermatology 2018 View  |  Download
Dulaglutide for Type 2 diabetes Dulaglutide (LY2189265; Trulicity) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2021 View  |  Download
Dronabinol for muscle spasticity caused by multiple sclerosis Dronabinol (BX-1; PPP-002; Syndros; Namisol; ECP002A) Muscle spasticity Musculoskeletal System , Neurology 2021 View  |  Download
Dostarlimab with paclitaxel and carboplatin for recurrent or primary advanced endometrial cancer Carboplatin (Paraplatin) , Dostarlimab (TSR-042; Jemperli) , Paclitaxel (Taxol; paclitaxel albumin) Endometrial cancer Female Reproductive Cancer 2023 View  |  Download
Dostarlimab with chemotherapy and niraparib for treating advanced epithelial ovarian cancers – first line Chemotherapy , Dostarlimab (TSR-042; Jemperli) , Niraparib (Zejula; MK 4827; JNJ 64091742; GSK 3985771; niraparib tosylate monohydrate) Epithelial ovarian cancers Female Reproductive Cancer 2023 View  |  Download
Dostarlimab in addition to carboplatin and paclitaxel for recurrent or primary advanced endometrial cancer Carboplatin (Paraplatin) , Dostarlimab (TSR-042; Jemperli) , Paclitaxel (Taxol; paclitaxel albumin) Endometrial cancer Female Reproductive Cancer 2021 View  |  Download
Donanemab for treating early symptomatic Alzheimer's disease Donanemab Alzheimer's disease Neurology 2022 View  |  Download
Domagrozumab (PF-6252616) for Duchenne muscular dystrophy in children and adolescents Domagrozumab (PF-06252616) Duchenne muscular dystrophy (DMD) Genetic Disorders , Musculoskeletal System 2017 View 
1 2 83 84 85 86 87 113 114
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications